Top compounds associated with response to TRIM16L


Feature Type Standardized
Nominal ANOVA
mRNA TG-100-115 CTRPv2 pan-cancer AAC -0.068 0.08
mRNA Irinotecan CCLE pan-cancer AAC 0.09 0.08
mRNA Vorinostat gCSI pan-cancer AAC -0.1 0.08
mRNA erlotinib:PLX-4032 (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.069 0.09
mRNA PD318088 CTRPv2 pan-cancer AAC -0.064 0.09
mRNA decitabine:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC -0.057 0.09
mRNA BRD9647 CTRPv2 pan-cancer AAC -0.069 0.09
mRNA AC55649 CTRPv2 pan-cancer AAC -0.069 0.09
mRNA IU1 CTRPv2 pan-cancer AAC -0.072 0.09
mRNA SU11274 CTRPv2 pan-cancer AAC -0.064 0.09
Download CSV